Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biomarker for Hunter Disease (BioHunt)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Rostock
Sponsor:
Collaborator:
Centogene AG Rostock
Information provided by (Responsible Party):
Prof. Dr. Arndt Rolfs, University of Rostock
ClinicalTrials.gov Identifier:
NCT01330277
First received: April 4, 2011
Last updated: October 2, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2019
  Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)